Synthetic data, generated through artificial intelligence technologies such as generative adversarial networks and latent ...

The COVID-19 pandemic reminded us of what vaccines can do to prevent life-threatening diseases.1 Respiratory infections such ...

The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...

Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...

I have had Parkinson's [disease] for about 10 years now”, says Ian Temple, an ambassador for and dancer with Dance for ...

The UN has declared November 24 as World Conjoined Twins Day,1 an initiative led by Saudi Arabia to raise global awareness about the medical and societal challenges faced by conjoined twins and their ...

The centrality of the first 1000 days—from conception to 2 years of age—for early childhood development is recognised in ...

The 2024 Access to Medicine Index shows that some manufacturers are increasingly prioritising LMICs, but broader interest in equitable access is waning. Udani Samarasekera reports.

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...